Family history of cardiovascular disease.
作者信息
Kolber Michael R, Scrimshaw Cathy
机构信息
Associate Professor in the Department of Family Medicine at the University of Alberta in Edmonton.
Clinical Lecturer at the University of Calgary in Alberta.
出版信息
Can Fam Physician. 2014 Nov;60(11):1016.
Abstract
摘要
相似文献
1
Family history of cardiovascular disease.
Can Fam Physician. 2014 Nov;60(11):1016.
2
A positive family history for premature cardiovascular disease identifies patients prone to recurrent arterial thrombotic events.
Eur J Prev Cardiol. 2012 Dec;19(6):1465-73. doi: 10.1177/1741826711422989. Epub 2011 Sep 13.
3
Improving assessment of cardiovascular disease risk by using family history: an integrative literature review.
J Cardiovasc Nurs. 2013 Nov-Dec;28(6):E18-27. doi: 10.1097/JCN.0b013e318294b206.
4
A clinical approach to inherited hypertrophy: the use of family history in diagnosis, risk assessment, and management.
Circ Cardiovasc Genet. 2013 Feb;6(1):118-31. doi: 10.1161/CIRCGENETICS.110.959387.
5
Influence of family history of cardiovascular disease on clinicians' preventive recommendations and subsequent adherence of patients without cardiovascular disease.
Public Health Genomics. 2010;13(7-8):457-66. doi: 10.1159/000293991. Epub 2010 Mar 17.
6
Genetics and cardiovascular disease.
Ethn Dis. 2004 Autumn;14(4):S2-8-16.
7
Commentary: Controversies in NICE guidance on familial hypercholesterolaemia.
BMJ. 2008 Aug 27;337:a1304. doi: 10.1136/bmj.a1304.
8
Genetic polymorphisms that predict outcome and need for treatment in cardiovascular disease.
Curr Opin Crit Care. 2006 Oct;12(5):420-5. doi: 10.1097/01.ccx.0000244120.54495.be.
9
Clinical validation of genetic markers for improved risk estimation.
Eur J Prev Cardiol. 2012 Aug;19(2 Suppl):25-32. doi: 10.1177/2047487312448993.
10
Recurrent strokes--an interesting pedigree.
J Assoc Physicians India. 2001 Jul;49:765-6.
引用本文的文献
1
Association of family history of cardiovascular disease with the prevalence of cardiometabolic risk factors in young adults in the United Arab Emirates: The UAE healthy future study.
PLoS One. 2025 Mar 12;20(3):e0319648. doi: 10.1371/journal.pone.0319648. eCollection 2025.
2
Cardiac Repair and Regeneration via Advanced Technology: Narrative Literature Review.
JMIR Biomed Eng. 2025 Mar 8;10:e65366. doi: 10.2196/65366.
3
Coronary risk factor profiles according to different age categories in premature coronary artery disease patients who have undergone percutaneous coronary intervention.
Sci Rep. 2024 Jul 3;14(1):15326. doi: 10.1038/s41598-024-53539-6.
4
Cardiovascular Risk Factors Among First-Degree Relatives of Patients with Premature Cardiovascular Disease in Malta. Baseline Findings from the CRISO Project.
Vasc Health Risk Manag. 2024 Apr 9;20:167-176. doi: 10.2147/VHRM.S449672. eCollection 2024.
5
Cross Talks between CNS and CVS Diseases: An Alliance to Annihilate.
Curr Cardiol Rev. 2024;20(3):63-76. doi: 10.2174/011573403X278550240221112636.
6
Current RNA strategies in treating cardiovascular diseases.
Mol Ther. 2024 Mar 6;32(3):580-608. doi: 10.1016/j.ymthe.2024.01.028. Epub 2024 Jan 29.
7
Cardiovascular Disease in Childhood, Adolescent, and Young Adult Cancer Survivors: The Impact of Family History of Premature Heart Disease.
J Adolesc Young Adult Oncol. 2024 Jun;13(3):548-556. doi: 10.1089/jayao.2023.0130. Epub 2024 Jan 23.
8
How Do Minerals, Vitamins, and Intestinal Microbiota Affect the Development and Progression of Heart Disease in Adult and Pediatric Patients?
Nutrients. 2023 Jul 24;15(14):3264. doi: 10.3390/nu15143264.
9
Prevalence and factors associated with undiagnosed and uncontrolled heart disease: A study based on self-reported chronic heart disease and symptom-based angina pectoris among middle-aged and older Indian adults.
PLoS One. 2023 Jun 28;18(6):e0287455. doi: 10.1371/journal.pone.0287455. eCollection 2023.
10
Bridging the Granularity Gap in Family History Information Extracted from Clinical Narratives.
AMIA Annu Symp Proc. 2023 Apr 29;2022:795-804. eCollection 2022.
本文引用的文献
1
2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
Circulation. 2014 Jun 24;129(25 Suppl 2):S49-73. doi: 10.1161/01.cir.0000437741.48606.98. Epub 2013 Nov 12.
2
2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult.
Can J Cardiol. 2013 Feb;29(2):151-67. doi: 10.1016/j.cjca.2012.11.032.
3
Association between family history and coronary heart disease death across long-term follow-up in men: the Cooper Center Longitudinal Study.
Circulation. 2012 Jun 26;125(25):3092-8. doi: 10.1161/CIRCULATIONAHA.111.065490. Epub 2012 May 23.
4
ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).
Eur Heart J. 2011 Jul;32(14):1769-818. doi: 10.1093/eurheartj/ehr158. Epub 2011 Jun 28.
5
Parental history and myocardial infarction risk across the world: the INTERHEART Study.
J Am Coll Cardiol. 2011 Feb 1;57(5):619-27. doi: 10.1016/j.jacc.2010.07.054.
6
Derivation, validation, and evaluation of a new QRISK model to estimate lifetime risk of cardiovascular disease: cohort study using QResearch database.
BMJ. 2010 Dec 9;341:c6624. doi: 10.1136/bmj.c6624.
7
Sibling cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults.
JAMA. 2005 Dec 28;294(24):3117-23. doi: 10.1001/jama.294.24.3117.
8
Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults: a prospective study of parents and offspring.
JAMA. 2004 May 12;291(18):2204-11. doi: 10.1001/jama.291.18.2204.
9
Genetic susceptibility to death from coronary heart disease in a study of twins.
N Engl J Med. 1994 Apr 14;330(15):1041-6. doi: 10.1056/NEJM199404143301503.
Zotero 插件